Another Chinese Covid-19 vaccine enters late-stage human trials
Beijing: Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has commenced the phase-3 clinical trials for its Covid-19 vaccine, planning to recruit 29,000 volunteers across the world.
This is China's first phase-3…